ONCOLUX
ActiveSummary
ONCOLUX has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €408k and a net result of €80k. Equity is growing by ~11.4% per year across the filed fiscal years. Its solvency ranks better than 94% of 16618 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability92▼-7
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days acceptable
Liquidity ample (current ratio 38.0 against 27.4 in 2024; short-term debt: 2.4% and cash: 23.4% of total assets), and 3.5% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
96.5%
Return on assets
19%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
1 d early
2024
29 d late
2023
28 d early
2022
30 d late
2021
30 d late
2020
30 d late
2019
42 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
History
Financials · fiscal year 2025, micro schema
Equity
€408k▲ 12.3%
2024 · €363k
Total assets
€423k▲ 10.7%
2024 · €382k
Net result
€80k▼ 12.4%
2024 · €92k
Working capital
€371k▲ 1.2%
2024 · €367k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€60k▲ 3.0%€90k▲ 50.8%€147k▲ 63.6%€134k▼ 9.1%€119k▼ 11.5%
Net result€42k▲ 4.1%€64k▲ 51.9%€99k▲ 55.4%€92k▼ 7.9%€80k▼ 12.4%
Equity€286k▲ 16.5%€348k▲ 21.8%€306k▼ 12.1%€363k▲ 18.6%€408k▲ 12.3%
Total assets€311k▲ 13.4%€372k▲ 19.7%€330k▼ 11.2%€382k▲ 15.7%€423k▲ 10.7%
Debt€21k▼ 15.6%€20k▼ 5.8%€18k▼ 9.3%€19k▲ 5.8%€15k▼ 21.7%
Working capital€276k▲ 20.1%€345k▲ 24.9%€312k▼ 9.6%€367k▲ 17.6%€371k▲ 1.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 11% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €423k
Fixed assets
€42k ▲ 2,436%
Current assets
€381k ▲ 0.2%
Equity and liabilities €423k
Equity
€408k ▲ 12.3%
Debt
€15k ▼ 21.7%
Debt's share of the balance-sheet total falls from 4.9% to 3.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€121k▼
2024 · €135k
Cash flow
€83k▼
2024 · €93k
Current ratio
38.00▲
2024 · 27.40
Debt to equity
0.04▼
2024 · 0.05
ROE
19.7%▼
2024 · 25.2%
ROA
19.0%▼
2024 · 24.0%
Interest coverage
464.77▼
2024 · 567.71
Debt ≤ 1 year
€10k▼
2024 · €14k
Income taxes
€38k▼
2024 · €44k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €7k | €7k | €7k | €1k | €3k | ▲ 97.1% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | - | - | €2k | €-6k | - | - |
| Other operating charges640/8 | €593 | €600 | €675 | €674 | €705 | ▲ 4.6% |
| Gross operating margin9900 | €67k | €98k | €157k | €129k | €122k | ▼ 5.9% |
| Operating profit (loss)9901 | €60k | €90k | €147k | €134k | €119k | ▼ 11.5% |
| Financial income75/76B | - | - | €1k | €2k | €122 | ▼ 93.2% |
| Recurring financial income75 | - | - | €1k | €2k | €122 | ▼ 93.2% |
| Financial charges65/66B | €685 | €848 | €859 | €238 | €261 | ▲ 9.4% |
| Recurring financial charges65 | €685 | €848 | €859 | €238 | €261 | ▲ 9.4% |
| Profit (loss) for the period before taxes9903 | €59k | €89k | €147k | €135k | €118k | ▼ 12.6% |
| Income taxes67/77 | €17k | €25k | €48k | €44k | €38k | ▼ 12.9% |
| Profit (loss) for the period9904 | €42k | €64k | €99k | €92k | €80k | ▼ 12.4% |
| Profit (loss) for the period to be appropriated9905 | €42k | €64k | €99k | €92k | €80k | ▼ 12.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €311k | €372k | €330k | €382k | €423k | ▲ 10.7% |
| Fixed assets21/28 | €14k | €8k | €862 | €2k | €42k | ▲ 2,436% |
| Tangible fixed assets22/27 | €14k | €8k | €812 | €2k | €42k | ▲ 2,515% |
| Plant, machinery and equipment23 | €417 | €297 | €177 | €57 | - | - |
| Furniture and vehicles24 | €14k | €7k | €635 | €2k | €42k | ▲ 2,612% |
| Financial fixed assets28 | €50 | €50 | €50 | €50 | - | - |
| Current assets29/58 | €297k | €364k | €330k | €380k | €381k | ▲ 0.2% |
| Amounts receivable within one year40/41 | €68k | €59k | €54k | €50k | €80k | ▲ 58.7% |
| Trade receivables40 | €59k | €53k | €54k | €38k | €47k | ▲ 25.4% |
| Other amounts receivable41 | €9k | €6k | - | €13k | €33k | ▲ 159% |
| Current investments50/53 | - | - | €182k | €200k | €200k | = |
| Cash at bank and in hand54/58 | €228k | €304k | €93k | €128k | €99k | ▼ 22.4% |
| Deferred charges and accrued income490/1 | €933 | €1k | €1k | €2k | €2k | ▼ 13.0% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €311k | €372k | €330k | €382k | €423k | ▲ 10.7% |
| Equity10/15 | €286k | €348k | €306k | €363k | €408k | ▲ 12.3% |
| Contributions10/11 | €12k | €12k | - | - | - | - |
| Reserves13 | €274k | €336k | €306k | €363k | €408k | ▲ 12.3% |
| Non-distributable reserves130/1 | €7k | €7k | - | - | - | - |
| Reserves not available under the articles1311 | €7k | €7k | - | - | - | - |
| Distributable reserves133 | €267k | €329k | €306k | €363k | €408k | ▲ 12.3% |
| Provisions and deferred taxes16 | €4k | €4k | €6k | - | - | - |
| Provisions for liabilities and charges160/5 | €4k | €4k | €6k | - | - | - |
| Other liabilities and charges164/5 | €4k | €4k | €6k | - | - | - |
| Amounts payable17/49 | €21k | €20k | €18k | €19k | €15k | ▼ 21.7% |
| Amounts payable within one year42/48 | €21k | €19k | €18k | €14k | €10k | ▼ 27.8% |
| Trade debts44 | €2k | €2k | €48 | €4k | €8k | ▲ 127% |
| Suppliers440/4 | €2k | €2k | €48 | €4k | €8k | ▲ 127% |
| Taxes, remuneration and social security45 | €605 | €757 | €9k | €8k | €500 | ▼ 94.1% |
| Taxes450/3 | €605 | €757 | €9k | €8k | €500 | ▼ 94.1% |
| Other amounts payable47/48 | €18k | €17k | €9k | €2k | €1k | ▼ 28.9% |
| Accrued charges and deferred income492/3 | €45 | €41 | €38 | €5k | €5k | ▼ 4.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €42k | €64k | €99k | €92k | €80k | ▼ 12.4% |
| + Depreciation and write-downs630 | €7k | €7k | €7k | €1k | €3k | ▲ 97.1% |
| Operating cash flow (approximation) | €49k | €71k | €106k | €93k | €83k | ▼ 10.8% |
| Investment in fixed assets (approximation) | - | €-658 | €0 | €-2k | €-43k | ▼ 1,929% |
| Change in cash | - | €76k | €-211k | €35k | €-29k | ▼ 182% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
More with these figures Sector benchmark What changed Value indication
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
03-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2018net €99k ▲55.4%
Operating result €147k, net result €99k, both a record.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 30 days late
2022
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
2021
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 30 days late
2020
31-12
Financial
Liquidity doublescurrent ratio 10.37
Current ratio from 4.87 to 10.37; short-term debt falls from €48k to €25k.
11-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 42 days late
2019
31-12
Financial
Equity above €200kEq €207k ▲19.9%
2 profitable years in a row build equity to €207k.
23-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 23 days late
2018
29-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 29 days late
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts
We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Meix-devant-Virton
Ground area
1,847 m²
Building footprint
167 m²
Volume, LiDAR
1,029 m³
Parcel 85028B0464/00W000, Wallonia · tallest building 8.6 m, ±2 floors. Linked by address, not a title deed.
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 85028B0464/00W000 | Wallonia | 1,847 m² | 1 · 167 m² | 8.6 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
549300W3VPMDHXJHCG72
Similar companies · same sector, comparable size
VINCIANE ROLAND
BE 0881.365.358
Namur · Eq €408,093
TALLA MEDICAL
BE 0887.237.521
Walcourt · Eq €408,511
DOKTER VICTOR ISSA
BE 0764.696.233
Willebroek · Eq €407,691
VALDESRO
BE 0821.203.087
Sint-Niklaas · Eq €408,602
Dr. Maes Jen Neuroloog
BE 0599.822.264
Kortemark · Eq €408,617
Of 16,630 companies in sector 86220 we hold annual accounts for 7,979. 6,560 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded19-04-2001
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
70200Business and other management consultancy
Scores and ratios are computed by Checked and are not a credit decision.